对I期癌症试验的剂量个性化,扩大了资格
Rebecca B Silva1, Bin Cheng1, Richard D Carvajal2
1Department of Biostatistics, Columbia University Mailman School of Public Health, New York, New York.
Statistics in medicine
|October 31, 2024
概括
这项研究引入了癌症试验的新设计,它解释了未知的患者差异. 它通过识别具有不同毒性概况的子组来确保更安全,更准确的药物剂量.
科学领域:
- 临床试验 临床试验
- 在瘤学瘤学.
- 生物统计学 生物统计学
背景情况:
- 在癌症试验中扩大资格标准提高了概括性和招聘.
- 然而,扩展的标准需要仔细设计,以确保患者的安全性和剂量效率.
- 现有的剂量确定方法通常假定已知的患者异质性,这不足以扩大资格.
研究的目的:
- 为I期癌症试验提出一种新的剂量检测设计,以扩大符合条件和未知的患者异质性.
- 同时确定区分患者标准,并推特定亚种群的最大耐受剂量 (MTD).
- 为了解决在剂量确定过程中假设患者均性的局限性.
主要方法:
- 开发了一个两合一的剂量检测设计,整合了标准选择和MTD建议.
- 采用随机搜索变量选择来识别具有明显毒性概况的患者子组.
- 进行模拟研究,将拟议设计与天真的同质性假设方法进行比较.
主要成果:
- 拟议的设计在各种场景中表现出了有利的操作特性.
- 它在试验中更有效地将患者分配给他们的真实MTD.
- 设计成功地确定了区分标准,并在必要时推多个MTD.
结论:
- 在剂量确定过程中假定患者均性可能会导致不安全或次治疗剂量建议.
- 拟议的设计有效地处理在扩大资格癌症试验中未知的患者异质性.
- 这种方法提高了早期试验的可变性,从而导致更精确,更安全的MTD建议.
更多相关视频
相关概念视频
Clinical Trials: Overview
2.8K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.8K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
Drug Administration and Therapy Phases: Overview
411
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
411
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


